# pathway_0073

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **D** — Secondary metabolite biosynthesis

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MLNLTNVDDALHKGEEWLETNKKTFLSETETGISFKDNFADLLLLELSNRWDYPVIVPEDYPEDNDTNAVAFSILKPTDSRAKVLIDEILACKNADGIVQVHLDPNRPRIAPEVSANILSLFYSYGRGHEVQESLSYLQKAMALEEYQESRYYFLPEPLFFYTWRLLCIASGSALETIDNQRLPKELHTLRDHLIRRVSARLGTAKDNALCPALRILICHSLGIKNDVDLQLLLDLQEDDGSFGRAWFEGLDPSSARLHERGLHAARKTENNPRPPSDMQQRIHDPQMQYARWSDWPLAPSIARNDKGIQHDHHTLGSLESPRPSHDLLLLHH

[Multiple Choices]
A. L-isoleucine biosynthesis
B. L-isoleucine from 2-oxobutanoate: step 3/4. .
C. Antibiotic biosynthesis. .
D. Secondary metabolite biosynthesis
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence exactly matches the UniProt entry annotated as terpene cyclase vviB, with the pathway listed as secondary metabolite biosynthesis and terpenoid biosynthesis. The pathway annotation cites experimental evidence from a publication; this supports D for this protein, though the primary study was not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence and choices alone provide no sufficiently specific biological clue to identify this protein as a terpene cyclase in a secondary-metabolite pathway rather than an enzyme in one of the other listed pathways.


**Missing item-specific fact**

> The protein-specific functional/pathway annotation or equivalent experimental characterization identifying vviB as a terpene cyclase involved in terpenoid biosynthesis.


**Reason**

> The matching pathway annotation supports the key, but that information is reviewer-only. Recognizing the exact sequence or relying on a general sequence-based prediction would not supply a concrete distinguishing argument from the question input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The evidence specifically associates this protein with terpenoid secondary-metabolite biosynthesis; it does not support the isoleucine or antibiotic-biosynthesis choices. D is the matching broad pathway option.


### Important caveats

- The historical UniProt record also matches the supplied sequence and gives the pathway annotation, but the author's exact source snapshot is unknown.
- The cited evidence code indicates experimental support in the database annotation; the cited publication was not independently validated in this review.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence and choices alone provide no sufficiently specific biological clue to identify this protein as a terpene cyclase in a secondary-metabolite pathway rather than an enzyme in one of the other listed pathways.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional/pathway annotation or equivalent experimental characterization identifying vviB as a terpene cyclase involved in terpenoid biosynthesis.",
    "reason": "The matching pathway annotation supports the key, but that information is reviewer-only. Recognizing the exact sequence or relying on a general sequence-based prediction would not supply a concrete distinguishing argument from the question input."
  },
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt entry annotated as terpene cyclase vviB, with the pathway listed as secondary metabolite biosynthesis and terpenoid biosynthesis. The pathway annotation cites experimental evidence from a publication; this supports D for this protein, though the primary study was not independently reviewed here."
  },
  "important_caveats": [
    "The historical UniProt record also matches the supplied sequence and gives the pathway annotation, but the author's exact source snapshot is unknown.",
    "The cited evidence code indicates experimental support in the database annotation; the cited publication was not independently validated in this review."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence specifically associates this protein with terpenoid secondary-metabolite biosynthesis; it does not support the isoleucine or antibiotic-biosynthesis choices. D is the matching broad pathway option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt entry annotated as terpene cyclase vviB, with the pathway listed as secondary metabolite biosynthesis and terpenoid biosynthesis. The pathway annotation cites experimental evidence from a publication; this supports D for this protein, though the primary study was not independently reviewed here.",
    "evidence_ids": ["C1", "C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence and choices alone provide no sufficiently specific biological clue to identify this protein as a terpene cyclase in a secondary-metabolite pathway rather than an enzyme in one of the other listed pathways.",
    "missing_item_specific_fact": "The protein-specific functional/pathway annotation or equivalent experimental characterization identifying vviB as a terpene cyclase involved in terpenoid biosynthesis.",
    "reason": "The matching pathway annotation supports the key, but that information is reviewer-only. Recognizing the exact sequence or relying on a general sequence-based prediction would not supply a concrete distinguishing argument from the question input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence specifically associates this protein with terpenoid secondary-metabolite biosynthesis; it does not support the isoleucine or antibiotic-biosynthesis choices. D is the matching broad pathway option."
  },
  "important_caveats": [
    "The historical UniProt record also matches the supplied sequence and gives the pathway annotation, but the author's exact source snapshot is unknown.",
    "The cited evidence code indicates experimental support in the database annotation; the cited publication was not independently validated in this review."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry for this sequence (A0A6A6H2E0, VVIB_VIRVR) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987). The protein is a terpene cyclase (EC 4.2.3.-) involved in Sporulositol A biosynthesis in the lichen-forming fungus Viridothelium virens. The expected answer D ('Secondary metabolite biosynthesis') is a direct match to the UniProt pathway annotation.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A knowledgeable reader could weakly argue that the 333-aa sequence lacks ACT domains, threonine deaminase motifs, or other hallmarks of amino acid biosynthesis enzymes, making options A and B less plausible. However, distinguishing D (secondary metabolite biosynthesis) from C (antibiotic biosynthesis) requires knowing the specific product identity: Sporulositol A is a terpenoid classified under general secondary metabolite biosynthesis, not an antibiotic. This product-specific classification is not derivable from the sequence alone.


**Missing item-specific fact**

> The identification of this sequence as a terpene cyclase (vviB) and the experimental determination that its product, Sporulositol A, is a terpenoid secondary metabolite rather than an antibiotic. The sequence lacks obvious, widely-recognized terpene cyclase motifs (DDxxD, NSE/DTE triads) that would allow confident identification without database lookup or specialized training. The distinction between 'antibiotic biosynthesis' (C) and 'secondary metabolite biosynthesis' (D) depends on knowing the specific compound's classification from the 2024 Tang & Zou study.


**Reason**

> Without recognizing this as terpene cyclase vviB from Viridothelium virens and knowing that Sporulositol A is a non-antibiotic terpenoid, a model cannot reliably distinguish C from D. Both are plausible categories for a fungal terpene cyclase. The correct answer depends on the specific UniProt annotation derived from experimental work, not on generalizable sequence-based reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "C",
  "D"
]
```

> Both 'Antibiotic biosynthesis' (C) and 'Secondary metabolite biosynthesis' (D) are plausible for a fungal terpene cyclase. Antibiotic biosynthesis is a subset of secondary metabolite biosynthesis, and without knowing that Sporulositol A is specifically a terpenoid (not an antibiotic), a model could defensibly select either. The UniProt annotation resolves this in favor of D, but the sequence alone does not clearly exclude C.


### Important caveats

- The UniProt pathway annotation carries experimental evidence (ECO:0000269) from PubMed:39310987 (Tang & Zou, Org. Lett. 2024), making the key scientifically well-supported.
- The protein was integrated into Swiss-Prot only on 2025-04-09; the author's source snapshot is unknown. The annotation may not have been available at the time the benchmark was constructed.
- The sequence does not contain easily recognizable canonical terpene cyclase motifs (DDxxD, NSE/DTE) in an obvious arrangement, making de novo identification from sequence alone very difficult.
- Options A and B (L-isoleucine biosynthesis) are clearly incorrect for a terpene cyclase, serving as easy distractors.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A knowledgeable reader could weakly argue that the 333-aa sequence lacks ACT domains, threonine deaminase motifs, or other hallmarks of amino acid biosynthesis enzymes, making options A and B less plausible. However, distinguishing D (secondary metabolite biosynthesis) from C (antibiotic biosynthesis) requires knowing the specific product identity: Sporulositol A is a terpenoid classified under general secondary metabolite biosynthesis, not an antibiotic. This product-specific classification is not derivable from the sequence alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identification of this sequence as a terpene cyclase (vviB) and the experimental determination that its product, Sporulositol A, is a terpenoid secondary metabolite rather than an antibiotic. The sequence lacks obvious, widely-recognized terpene cyclase motifs (DDxxD, NSE/DTE triads) that would allow confident identification without database lookup or specialized training. The distinction between 'antibiotic biosynthesis' (C) and 'secondary metabolite biosynthesis' (D) depends on knowing the specific compound's classification from the 2024 Tang & Zou study.",
    "reason": "Without recognizing this as terpene cyclase vviB from Viridothelium virens and knowing that Sporulositol A is a non-antibiotic terpenoid, a model cannot reliably distinguish C from D. Both are plausible categories for a fungal terpene cyclase. The correct answer depends on the specific UniProt annotation derived from experimental work, not on generalizable sequence-based reasoning."
  },
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A6A6H2E0, VVIB_VIRVR) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987). The protein is a terpene cyclase (EC 4.2.3.-) involved in Sporulositol A biosynthesis in the lichen-forming fungus Viridothelium virens. The expected answer D ('Secondary metabolite biosynthesis') is a direct match to the UniProt pathway annotation."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries experimental evidence (ECO:0000269) from PubMed:39310987 (Tang & Zou, Org. Lett. 2024), making the key scientifically well-supported.",
    "The protein was integrated into Swiss-Prot only on 2025-04-09; the author's source snapshot is unknown. The annotation may not have been available at the time the benchmark was constructed.",
    "The sequence does not contain easily recognizable canonical terpene cyclase motifs (DDxxD, NSE/DTE) in an obvious arrangement, making de novo identification from sequence alone very difficult.",
    "Options A and B (L-isoleucine biosynthesis) are clearly incorrect for a terpene cyclase, serving as easy distractors."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "C",
      "D"
    ],
    "reason": "Both 'Antibiotic biosynthesis' (C) and 'Secondary metabolite biosynthesis' (D) are plausible for a fungal terpene cyclase. Antibiotic biosynthesis is a subset of secondary metabolite biosynthesis, and without knowing that Sporulositol A is specifically a terpenoid (not an antibiotic), a model could defensibly select either. The UniProt annotation resolves this in favor of D, but the sequence alone does not clearly exclude C."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A6A6H2E0, VVIB_VIRVR) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987). The protein is a terpene cyclase (EC 4.2.3.-) involved in Sporulositol A biosynthesis in the lichen-forming fungus Viridothelium virens. The expected answer D ('Secondary metabolite biosynthesis') is a direct match to the UniProt pathway annotation.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A knowledgeable reader could weakly argue that the 333-aa sequence lacks ACT domains, threonine deaminase motifs, or other hallmarks of amino acid biosynthesis enzymes, making options A and B less plausible. However, distinguishing D (secondary metabolite biosynthesis) from C (antibiotic biosynthesis) requires knowing the specific product identity: Sporulositol A is a terpenoid classified under general secondary metabolite biosynthesis, not an antibiotic. This product-specific classification is not derivable from the sequence alone.",
    "missing_item_specific_fact": "The identification of this sequence as a terpene cyclase (vviB) and the experimental determination that its product, Sporulositol A, is a terpenoid secondary metabolite rather than an antibiotic. The sequence lacks obvious, widely-recognized terpene cyclase motifs (DDxxD, NSE/DTE triads) that would allow confident identification without database lookup or specialized training. The distinction between 'antibiotic biosynthesis' (C) and 'secondary metabolite biosynthesis' (D) depends on knowing the specific compound's classification from the 2024 Tang & Zou study.",
    "reason": "Without recognizing this as terpene cyclase vviB from Viridothelium virens and knowing that Sporulositol A is a non-antibiotic terpenoid, a model cannot reliably distinguish C from D. Both are plausible categories for a fungal terpene cyclase. The correct answer depends on the specific UniProt annotation derived from experimental work, not on generalizable sequence-based reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["C", "D"],
    "reason": "Both 'Antibiotic biosynthesis' (C) and 'Secondary metabolite biosynthesis' (D) are plausible for a fungal terpene cyclase. Antibiotic biosynthesis is a subset of secondary metabolite biosynthesis, and without knowing that Sporulositol A is specifically a terpenoid (not an antibiotic), a model could defensibly select either. The UniProt annotation resolves this in favor of D, but the sequence alone does not clearly exclude C."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries experimental evidence (ECO:0000269) from PubMed:39310987 (Tang & Zou, Org. Lett. 2024), making the key scientifically well-supported.",
    "The protein was integrated into Swiss-Prot only on 2025-04-09; the author's source snapshot is unknown. The annotation may not have been available at the time the benchmark was constructed.",
    "The sequence does not contain easily recognizable canonical terpene cyclase motifs (DDxxD, NSE/DTE) in an obvious arrangement, making de novo identification from sequence alone very difficult.",
    "Options A and B (L-isoleucine biosynthesis) are clearly incorrect for a terpene cyclase, serving as easy distractors."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A6A6H2E0` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 12. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:29.065613+00:00.  

```json
"A0A6A6H2E0"
```

Source SHA-256: `3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:29.065613+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"39310987","source":"PubMed"}],"value":"Sporulositol A biosynthesis cluster protein B"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39310987","source":"PubMed"}],"value":"4.2.3.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"39310987","source":"PubMed"}],"value":"Terpene cyclase vviB"}}}
```

Source SHA-256: `3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:29.065613+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39310987","source":"PubMed"}],"value":"Secondary metabolite biosynthesis; terpenoid biosynthesis"}]}
```

Source SHA-256: `3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)  
**Locator:** `/references/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:29.065613+00:00.  

```json
{"citation":{"authors":["Tang Y.J.","Zou Y."],"citationCrossReferences":[{"database":"PubMed","id":"39310987"},{"database":"DOI","id":"10.1021/acs.orglett.4c03154"}],"citationType":"journal article","firstPage":"8366","id":"39310987","journal":"Org. Lett.","lastPage":"8370","publicationDate":"2024","title":"Cyclo-farnesyl Diphosphate-Dependent Prenylation in Fungi.","volume":"26"},"referenceNumber":2,"referencePositions":["FUNCTION","CATALYTIC ACTIVITY","PATHWAY"]}
```

Source SHA-256: `3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A6A6H2E0?format=txt&versions=12)  
**Locator:** `lines 45-46`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 12 / 1.  
**Retrieved:** 2026-11-02T04:25:33.124614+00:00.  

```text
CC   -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.
CC       {ECO:0000269|PubMed:39310987}.
```

Source SHA-256: `ba398b865fc9576814bd6954ed27346d14ab44b5850d578e50e8feb280836380`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 73. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
